Covington Capital Management - CRISPR THERAPEUTICS AG ownership

CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 444 filers reported holding CRISPR THERAPEUTICS AG in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.

Quarter-by-quarter ownership
Covington Capital Management ownership history of CRISPR THERAPEUTICS AG
ValueSharesWeighting
Q3 2022$32,000
+6.7%
4950.0%0.00%0.0%
Q2 2022$30,000
+20.0%
495
+25.3%
0.00%0.0%
Q1 2022$25,000
-16.7%
3950.0%0.00%0.0%
Q4 2021$30,000
-31.8%
3950.0%0.00%
-50.0%
Q3 2021$44,000
-31.2%
3950.0%0.00%
-33.3%
Q2 2021$64,000
+33.3%
3950.0%0.00%
+50.0%
Q1 2021$48,000
-20.0%
3950.0%0.00%
-33.3%
Q4 2020$60,000
+81.8%
3950.0%0.00%
+50.0%
Q3 2020$33,000
+13.8%
3950.0%0.00%0.0%
Q2 2020$29,000
+81.2%
395
+5.3%
0.00%
+100.0%
Q1 2020$16,000
-54.3%
375
-34.8%
0.00%
-50.0%
Q4 2019$35,000
+45.8%
5750.0%0.00%
+100.0%
Q3 2019$24,000
-11.1%
5750.0%0.00%
-50.0%
Q2 2019$27,000
+28.6%
5750.0%0.00%
+100.0%
Q1 2019$21,000
+31.2%
5750.0%0.00%0.0%
Q4 2018$16,000
-38.5%
5750.0%0.00%
-50.0%
Q3 2018$26,000
+18.2%
575
+53.3%
0.00%
+100.0%
Q2 2018$22,000
+29.4%
3750.0%0.00%0.0%
Q1 2018$17,000
+240.0%
375
+87.5%
0.00%
Q4 2017$5,000
+25.0%
2000.0%0.00%
Q3 2017$4,0002000.00%
Other shareholders
CRISPR THERAPEUTICS AG shareholders Q1 2022
NameSharesValueWeighting ↓
Gilfoyle Management LLC 150$6,37612.96%
Versant Venture Management, LLC 498,558$22,629,54812.03%
NEA Management Company, LLC 1,587,854$72,072,6935.57%
ARK Investment Management 7,163,118$325,133,9132.49%
Nikko Asset Management Americas, Inc. 3,465,470$157,263,0291.88%
Integral Health Asset Management, LLC 275,000$12,482,2501.73%
Merlin Capital, Inc 9,092$412,6861.54%
Del-Sette Capital Management, LLC 33,977$1,542,2161.52%
Green Alpha Advisors, LLC 34,880$1,583,2031.22%
Ikarian Capital, LLC 2,039$9,255,0211.11%
View complete list of CRISPR THERAPEUTICS AG shareholders